Can biocompatible dialysis fluids improve outcomes in peritoneal dialysis patients?
Woodrow
Graham
G
Renal Unit, Leeds General Infirmary, United Kingdom. graham.woodrow@leedsth.nhs.uk
D015314:Dialysis Solutions / Q000737:chemistry*; D005950:Glucose Solution, Hypertonic / Q000737:chemistry*; D017127:Glycation End Products, Advanced / Q000032:analysis*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects; D010538:Peritonitis / Q000209:etiology / Q000517:prevention & control; D051437:Renal Insufficiency / Q000401:mortality / Q000628:therapy*; D015996:Survival Rate; D016896:Treatment Outcome
D015314:Dialysis Solutions; D005950:Glucose Solution, Hypertonic; D017127:Glycation End Products, Advanced